Yorston D, Wood M, Foster A
Kikuyu Hospital, Kenya.
Br J Ophthalmol. 1996 Oct;80(10):890-4. doi: 10.1136/bjo.80.10.890.
To study the survival and visual outcome of penetrating keratoplasty in an African setting.
A retrospective analysis of 216 corneal grafts, performed on 203 eyes of 186 patients, at Kikuyu Hospital, Kenya over a 5 year period.
Half of the transplants were carried out for keratoconus with only 5% of the grafts being undertaken for corneal scarring caused by trachoma or measles. The average follow up was 27.3 months. The probability of graft survival at 2 years was 87.4% (95% CI 80.6%-94.3%) for keratoconus and 64.7% (95% CI 54.8%-74.6%) for other corneal pathologies. Forty seven grafts (21.8%) in 36 patients (17.7%) are known to have become opaque. The commonest causes of graft opacification were bacterial keratitis (6.0%), endothelial failure (6.0%), and graft rejection (5.1%). Preoperatively 55% of keratoconus eyes and 75.7% of non-keratoconus eyes were blind. Postoperatively, 5% of keratoconus eyes and 41.7% of the non-keratoconus eyes were blind. Normal vision was achieved in 53.7% of operated eyes. Grafts carried out for keratoconus had a better visual outcome than grafts performed for other corneal pathologies. Preoperatively, 12.4% of keratoconus and 48.5% of non-keratoconus patients were blind in their better eye. Postoperatively, 1.1% of keratoconus patients and 25.7% of non-keratoconus patients were blind. The number of patients with normal vision in the better eye increased from 32 (17.2%) to 106 (57.0%). Sight was restored to 34 blind patients, but two patients with severe visual impairment preoperatively were blind at their last follow up. There was therefore a net reduction of 32 in the number of blind patients after 216 keratoplasties.
Penetrating keratoplasty can be successful in Africa, particularly for keratoconus and other corneal dystrophies. However, penetrating keratoplasty has a limited role in the treatment of blindness from corneal scarring due to trachoma, measles, and vitamin A deficiency for which community based preventive measures must remain the priority.
研究在非洲环境下穿透性角膜移植术的存活率和视觉效果。
对肯尼亚基库尤医院在5年期间为186例患者的203只眼睛进行的216例角膜移植手术进行回顾性分析。
一半的移植手术是针对圆锥角膜进行的,只有5%的移植手术是针对沙眼或麻疹引起的角膜瘢痕进行的。平均随访时间为27.3个月。圆锥角膜移植在2年时的存活概率为87.4%(95%可信区间80.6%-94.3%),其他角膜病变的移植存活概率为64.7%(95%可信区间54.8%-74.6%)。已知36例患者(17.7%)的47只移植片(21.8%)变得混浊。移植片混浊的最常见原因是细菌性角膜炎(6.0%)、内皮功能衰竭(6.0%)和移植排斥反应(5.1%)。术前,55%的圆锥角膜眼和75.7%的非圆锥角膜眼失明。术后,5%的圆锥角膜眼和41.7%的非圆锥角膜眼失明。53.7%的手术眼获得了正常视力。针对圆锥角膜进行的移植比针对其他角膜病变进行的移植有更好的视觉效果。术前,12.4%的圆锥角膜患者和48.5%的非圆锥角膜患者较好眼失明。术后,1.1%的圆锥角膜患者和25.7%的非圆锥角膜患者较好眼失明。较好眼视力正常的患者数量从32例(17.2%)增加到106例(57.0%)。34例失明患者恢复了视力,但术前有2例严重视力损害患者在最后一次随访时仍失明。因此,216例角膜移植术后失明患者数量净减少了32例。
穿透性角膜移植术在非洲可以取得成功,特别是对于圆锥角膜和其他角膜营养不良。然而,穿透性角膜移植术在治疗沙眼、麻疹和维生素A缺乏引起的角膜瘢痕导致的失明方面作用有限,对此基于社区的预防措施仍应是首要任务。